[{"address1": "360 Massachusetts Avenue", "address2": "Suite 203", "city": "Acton", "state": "MA", "zip": "01720", "country": "United States", "phone": "844 327 7078", "website": "https://bluejaydx.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.", "fullTimeEmployees": 10, "maxAge": 86400, "priceHint": 4, "previousClose": 3.4, "open": 3.37, "dayLow": 2.94, "dayHigh": 3.37, "regularMarketPreviousClose": 3.4, "regularMarketOpen": 3.37, "regularMarketDayLow": 2.94, "regularMarketDayHigh": 3.37, "beta": 1.06, "forwardPE": -9.40625, "volume": 62792, "regularMarketVolume": 62792, "averageVolume": 46904, "averageVolume10days": 135534, "averageDailyVolume10Day": 135534, "bid": 3.1, "ask": 3.21, "bidSize": 100, "askSize": 100, "marketCap": 1697546, "fiftyTwoWeekLow": 2.62, "fiftyTwoWeekHigh": 111.8392, "fiftyDayAverage": 4.148536, "twoHundredDayAverage": 14.12451, "currency": "USD", "enterpriseValue": -1235642, "floatShares": 204673, "sharesOutstanding": 563969, "sharesShort": 840, "sharesShortPriorMonth": 46, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.09997, "heldPercentInstitutions": 0.095010005, "shortRatio": 0.1, "shortPercentOfFloat": 0.00029999999, "impliedSharesOutstanding": 563969, "bookValue": 10.02, "priceToBook": 0.30039918, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -9742510, "trailingEps": -60.64, "forwardEps": -0.32, "lastSplitFactor": "1:8", "lastSplitDate": 1718841600, "enterpriseToEbitda": 0.13, "52WeekChange": -0.9115983, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BJDX", "underlyingSymbol": "BJDX", "shortName": "Bluejay Diagnostics, Inc.", "longName": "Bluejay Diagnostics, Inc.", "firstTradeDateEpochUtc": 1636554600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "74bd969a-9ba0-37a6-9244-8da1cdf9cf23", "messageBoardId": "finmb_384143134", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.01, "targetHighPrice": 256.0, "targetLowPrice": 256.0, "targetMeanPrice": 256.0, "targetMedianPrice": 256.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 2661169, "totalCashPerShare": 7.33, "ebitda": -9511345, "totalDebt": 332728, "quickRatio": 1.744, "currentRatio": 2.261, "debtToEquity": 9.881, "returnOnAssets": -0.78771, "returnOnEquity": -1.5549899, "freeCashflow": -4569886, "operatingCashflow": -7676339, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]